Featured Reports
Corporate News and Events
CADTH Strategy 2022-2025: Anticipate, Innovate, and Transform
CADTH is pleased to share Ahead of the Curve: Shaping ...
Last Updated: May 9, 2022
This Horizon Scan summarizes the available information regarding the emerging technology of liquid biopsy–based multi-cancer early detection tests for ...
Last Updated: April 22, 2022
Tixagevimab and cilgavimab (Evusheld) is a combination of long-acting monoclonal antibodies for intramuscular administration that provides pre ...
Last Updated: April 20, 2022
Upcoming Events
Event date: Thursday, June 9, 2022
Time: 1:00 p.m. to 2:00 p.m. EDT
Zoom Webinar (Free — Registration Required)
Join Dr. Alexandra King and Mr ...
Event Date:
Event date: Friday, June 3, 2022
Time: 12:00 p.m. to 1:00 p.m. EDT
Zoom webinar (free although registration required)
Launched in 2014, Choosing ...
Event Date:
In the fall of 2021, CADTH published evidence and recommendations on the implementation of remote patient monitoring for cardiac conditions. The focus ...
Event Date:
Latest News
CADTH is expanding its Scientific Advice program to include applications for advice on real-world evidence (RWE) generation plans after protocols for ...
Published on: April 27, 2022
A message from David Agnew, Chair of the CADTH Board of Directors, and Suzanne McGurn, President and CEO of CADTH
We’re pleased to share Ahead of ...
Published on: April 5, 2022
CADTH is seeking nominations for its expert and advisory committees. We are currently accepting applications from individuals with significant ...
Published on: April 5, 2022